SelectQuote (SLQT) Q1 2027 Earnings Call Transcript
SelectQuote (SLQT) reported a Q1 2027 adjusted EBITDA loss of $17M, improved from last year. Revenue was $280M, down 15% YoY. Senior segment lost $12M (improved $9M YoY), while Healthcare Services EBITDA rose 56% YoY to $11M. The company reiterated its fiscal 2027 operating cash flow target of at least $60M, citing strong profitability and cash flow performance.
How this was made

The 30-second read
Why it matters
The disclosed revenue decline and loss may trigger short‑term price weakness, while operational improvements and AI initiatives could support longer‑term upside.
Market read
First‑time disclosure of Q1 numbers for SLQT; investors will reassess growth outlook and cost structure.
What to watch
Cost‑cutting measures and AI‑driven efficiency gains may boost margins in later quarters, offsetting short‑term revenue headwinds.
Background
SelectQuote (SLQT) provided its Q1 2027 earnings call transcript, detailing financial performance, segment results, and strategic initiatives.
Ticker impact
Q1 2027 earnings call disclosed adjusted EBITDA loss of $17M, revenue $280M, a 15% YoY decline and segment improvements.
likely downward pressure as investors digest lower revenue and loss, despite EBITDA improvement.
The transcript provides the first public release of Q1 numbers, showing a revenue decline and loss, which typically triggers sell‑side reaction.
Market effects
Highlights pressure on Medicare Advantage and health‑insurance distributors, may affect peers in the senior‑care benefits space.
U.S. health‑services sector could see modest pullback.
Limited to U.S. health‑insurance market; no broader macro impact.
Counterpoint
The EBITDA loss improvement and AI/technology investments could position SLQT for upside if the market overreacts to revenue decline.
Key entities
- companySelectQuote
U.S. health‑insurance distributor reporting Q1 2027 results.




